- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1) Registration Statement (Form S-3 No. 333-267712) of Tyra Biosciences, Inc., and
2) Registration Statement (Form S-8 No. 333-259560) pertaining to the Tyra Biosciences, Inc. 2020 Equity Incentive Plan, Tyra Biosciences, Inc. 2021 Incentive Award Plan, and the Tyra Biosciences, Inc. 2021 Employee Stock Purchase Plan of Tyra Biosciences, Inc.;
of our report dated March 22, 2023, with respect to the financial statements of Tyra Biosciences, Inc., included in this Annual Report (Form 10-K) of Tyra Biosciences, Inc. for the year ended December 31, 2022.
/s/ Ernst & Young LLP
San Diego, California
March 22, 2023